Add-on Acquisition • Life Science

Sesen Bio Acquires Viventia Bio

On September 21, 2016, Sesen Bio acquired life science company Viventia Bio

Acquisition Context

This is Sesen Bio’s 1st transaction in the Life Science sector.
This is Sesen Bio’s 1st transaction in Canada.
This is Sesen Bio’s 1st transaction in Ontario.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	September 21, 2016
Target	Viventia Bio
Sector	Life Science
Buyer(s)	Sesen Bio
Deal Type	Add-on Acquisition
Advisor(s)	Hogan Lovells (Legal)

Target Company

Viventia Bio

Winnipeg, Ontario, Canada

Viventia Bio, Inc. is a biopharmaceutical company specializing in the discovery and development of a new generation of immunotoxin products offering safer and more beneficial cancer therapies. Viventia Bio was established in 1983 and is headquartered in Winnipeg, Manitoba.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Sesen Bio

Cambridge, Massachusetts, United States

Category	Company
Founded	2008
Sector	Life Science
Employees	27
Revenue	40M USD (2022)

DESCRIPTION

Sesen is a biologics oncology company focused on the development of novel therapies based upon tumor targeting antibody fragments genetically fused to a cytotoxic protein payload called Targeted Protein Therapeutics (TPTs). Eleven Sesen Bio was founded in 2008 and is based in Cambridge, Massachusetts.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: Ontario	1 of 1
Country: Canada	1 of 1
Year: 2016	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Ontario M&A - Canada M&A - 2016 M&A